Tokyo, Japan

Masumi Murakami

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masumi Murakami. Retrieved from https://idiyas.com/inventor/masumi-murakami-yqle7q7b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masumi Murakami: Innovator in Immunology

Introduction

Masumi Murakami is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of immunology, particularly through her innovative work on IL-2 variants. Her research focuses on enhancing the selectivity and efficacy of immune therapies.

Latest Patents

Masumi Murakami holds a patent for an IL-2 variant. The objective of this invention is to provide a novel IL-2 variant that has improved selectivity for IL-2R and selectively activates regulatory T cells (Tregs). This patent encompasses various methods, including the production of the IL-2 variant, a composition and therapeutic agent for immune diseases, and methods for increasing the selectivity and affinity of IL-2 for its receptor subunits.

Career Highlights

Masumi Murakami is associated with Kyowa Kirin Co., Ltd., where she continues to advance her research in immunology. Her work has garnered attention for its potential applications in treating immune-related diseases.

Collaborations

Some of her notable coworkers include Masahiro Ikeda and Shinpei Yamaguchi. Their collaborative efforts contribute to the innovative research environment at Kyowa Kirin Co., Ltd.

Conclusion

Masumi Murakami's contributions to the field of immunology through her IL-2 variant patent highlight her role as a leading inventor in the industry. Her work promises to enhance therapeutic strategies for immune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…